Sally Sherif

• proactively drive deeper engagement on educational & scientific content with Dermatologists.
• streamline customer interface by acting as single POC for proactive & seamless (compliant) connection to Pfizer SMEs and resources within and outside the Category.
• responsible for onboarding customers to new operating model platforms (e.g., Digital Engagement Portal)
• having strong knowledgeable of customer preferences for content and channels to orchestrate an ideal customer experience through relevant content selection
• working with the Health Solutions Manager to attain improved patient outcomes through HCP and patient education and services enabled by deep scientific expertise
• provide insights to appropriate stakeholder to improve service provided to the customer along with design expertise
• Actively engage in creating awareness and shaping patient access initiatives (Commercial only) and help accelerate patient access through awareness and education addressing external bureaucracy

• Achieving sales targets, business Development and Identifying growth areas in Abu Dhabi & Alain
• Implement on going Targeting and segmentation of customers
• Fully Operational in sales Techniques, master all operational tools
• Regular visits of institution pharmacies to monitor product availability and movement
• Understand fully internal sales systems and procedure and develop weekly/ monthly visit plan in consultation with Product managers
• Maintain / update product Knowledge of the company
• Transfer Knowledge of company product to Pharmacists and Physicians
• Conducting presentations and round table discussions for Key opinion leaders.

• Achieving sales targets, business Development and Identifying growth areas in Qatar
• Inclusion of Inlyta and Lorbrena NCCCR
• Maintain the position of Ibrance as market leaders and identify new opportunities
• Maintain the position of Xalkori and sutent as 1st Line treatment for ALK+ NSCLC , MRCC
• Launching both of Lorbrena for ALK+ NSCLC and Talzenna for BRACA breast cancer
• Implement on going Targeting and segmentation of customers
• Fully Operational in sales Techniques, master all operational tools
• Regular visits of institution pharmacies to monitor product

· Achieving sales targets, business Development and Identifying growth areas in Qatar and Oman

· Maintain the position of Factor 8 as market leaders and identify new opportunities

· Fully Operational in sales Techniques, master all operational tools.

· Understand fully internal sales systems and procedure and develop weekly/ monthly visit plan in consultation with Product managers.

· Maintain / update product Knowledge of the company.

· Transfer Knowledge of company product to Pharmacists and Physicians.

Conducting Presentations and round table discussions for Key leaders on the efficacy, safety, dosage, recommendations and ensure company positioning

• Achieving sales targets, business Development and Identifying growth areas in Qatar and Oman
• Maintain the position of Factor 8 as market leaders and identify new opportunities
• Fully Operational in sales Techniques, master all operational tools
• Understand fully internal sales systems and procedure and develop weekly/ monthly visit plan in consultation with Product managers
• Maintain / update product Knowledge of the company
• Transfer Knowledge of company product to Pharmacists and Physicians
• Conducting Presentations and round table discussions for Key leaders on the efficacy, safety, dosage, recommendations and ensure company positioning, Promote IM line products to existing customers and identify new potential customers
• Achieve sales and business objectives
• Inclusion of Resolor in PHCS in Qatar
• Maintain position of Pariet as market leader, and explore new areas of growth
• Inclusion of Invokana in HMC
• Develop monthly plans and weekly reports
• Conduct presentations and scientific discussions with doctors
• Dealing with key opinion leader doctors
• Achievements:
• Achievements 2012 ( 114% vs plan with 27% growth vs prior )
• Achievements 2013 ( 111% vs plan with 24% growth vs prior )
• Achievements 2014 ( 103% vs plan YTD with 20% growth vs prior )
• Achieved the maximum of the incentive scheme 2015 (140% vs plan with 34% growth vs prior).